SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-23-009584
Filing Date
2023-01-17
Accepted
2023-01-17 17:26:07
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B5 d405392d424b5.htm 424B5 472451
2 GRAPHIC g405392g01s01.jpg GRAPHIC 44457
3 GRAPHIC g405392g04b38.jpg GRAPHIC 45492
4 GRAPHIC g405392g07s70.jpg GRAPHIC 75166
5 GRAPHIC g405392g07s71.jpg GRAPHIC 74460
  Complete submission text file 0001193125-23-009584.txt   796093
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 617-651-8851
Fulcrum Therapeutics, Inc. (Filer) CIK: 0001680581 (see all company filings)

IRS No.: 474839948 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-260754 | Film No.: 23532312
SIC: 2834 Pharmaceutical Preparations